Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
Key Information
Due Date: September 7, 2026
Agency: United States Department of Health and Human Services
Source: Federal
Website: View Website
Funding Categories:
Funding Amount: $500,000
Funding Type: Grant
Match Required: No
Status: Posted
Contact Info:
grantsinfo@nih.gov
NIH Grants Information grantsinfo@nih.gov
NIH Grants Information grantsinfo@nih.gov
Overview
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications development, precision medicine, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery.
Show More
Additional Info
Posted Date: November 27, 2024
Application Due Date: September 7, 2026
Estimated Award Date: Not Specified
Eligible Applicants:
- State governments
- Public and State controlled institutions of higher education
- Special district governments
- Private institutions of higher education
- Others
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Small businesses
- County governments
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- City or township governments
- For profit organizations other than small businesses
- Independent school districts
- Public housing authorities/Indian housing authorities
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Apply with Confidence
Our partners at Syncurrent help local governments move from searching to applying. Confirm eligibility, access funding documents, and begin building a complete application in a single secure platform.
